Alogliptin Benzoate 10 mg | Purity Not Available
TargetMol
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50
More Information Supplier PageAlogliptin Benzoate
Search Results
Alogliptin Benzoate 50 mg | Purity Not Available
TargetMol
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50
More Information Supplier PageAlogliptin Benzoate
Cinacalcet hydrochloride 10 mg | 99.90%
TargetMol
Cinacalcet hydrochloride is a naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-sensing receptors to serum calcium. This action reduces parathyroid hormone secretion and decreases serum calcium in the treatment of PARATHYROID DISEASES.
More Information Supplier PageCinacalcet hydrochloride
Cinacalcet hydrochloride 100 mg | 99.90%
TargetMol
Cinacalcet hydrochloride is a naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-sensing receptors to serum calcium. This action reduces parathyroid hormone secretion and decreases serum calcium in the treatment of PARATHYROID DISEASES.
More Information Supplier PageCinacalcet hydrochloride
Revaprazan hydrochloride 50 mg | Purity Not Available
TargetMol
Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.
More Information Supplier PageRevaprazan hydrochloride
Revaprazan hydrochloride 25 mg | Purity Not Available
TargetMol
Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.
More Information Supplier PageRevaprazan hydrochloride
Revaprazan hydrochloride 10 mg | Purity Not Available
TargetMol
Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.
More Information Supplier PageRevaprazan hydrochloride
Alogliptin Benzoate 5 mg | Purity Not Available
TargetMol
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50
More Information Supplier PageAlogliptin Benzoate
Edoxaban Tosylate Monohydrate 100 mg | Purity Not Available
TargetMol
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
More Information Supplier PageEdoxaban Tosylate Monohydrate
BRD7116 5 mg | 99.30%
TargetMol
BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.
More Information Supplier PageBRD7116
